Announcing Clinical Therapeutics Journal Club
An Innovative Online Forum
Bridgewater, NJ, October 5, 2006 - Excerpta Medica announces the launch of Clinical Therapeutics Journal Club - an innovative online resource offering the latest in pharmaceutical progress. Medical professionals can now keep pace with important clinical developments through the original research reports and expert reviews provided at CTJournalClub.com.
Articles accepted for publication in Excerpta Medica’s well-respected print journal Clinical Therapeutics will be considered for one of the featured spots on the CTJournalClub.com Web site. Each article will be accompanied by a short, insightful commentary provided by Clinical Therapeutics Editor-in-Chief, Philip D. Walson, MD, or another member of the Clinical Therapeutics distinguished Editorial Board.
CTJournalClub.com not only offers medical practitioners a convenient way of remaining current, it also offers clinical investigators and research sponsors the chance to extend the presence of their Clinical Therapeutics article. According to Vicki Donoso, Executive Publisher–Clinical Therapeutics, “CTJournalClub.com will provide clinical investigators a wonderful opportunity to further highlight and expand the reach of their clinical work in a scientifically credible forum.”About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications company that services global health care clients in the areas of medical education, medical communications, and publication planning. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, and medical publishing to deliver scientific and creative solutions. Excerpta Medica has offices in the US (Bridgewater, NJ) and The Netherlands (Amsterdam). About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 908 547-2070